SSA
EOLS icon

Schonfeld Strategic Advisors’s Evolus EOLS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,085
Closed -$157K – 2167
2025
Q1 		$157K Sell
13,085
-21,615
-62% -$283K ﹤0.01% 1968
2024
Q4 		$383K Buy
34,700
+13,363
+63% +$188K ﹤0.01% 1516
2024
Q3 		$346K Buy
21,337
+6,321
+42% +$88.4K ﹤0.01% 1590
2024
Q2 		$163K Buy
+15,016
New +$185K ﹤0.01% 1835
2024
Q1 		– Sell
-49,995
Closed -$526K – 2152
2023
Q4 		$526K Sell
49,995
-81,347
-62% -$727K ﹤0.01% 1273
2023
Q3 		$1.2M Buy
+131,342
New +$1.18M 0.01% 965
2023
Q1 		– Sell
-63,095
Closed -$474K – 2229
2022
Q4 		$474K Sell
63,095
-100,628
-61% -$779K ﹤0.01% 1557
2022
Q3 		$1.32M Buy
163,723
+90,034
+122% +$955K 0.01% 1103
2022
Q2 		$855K Buy
+73,689
New +$869K 0.01% 1091
2021
Q3 		– Sell
-394,214
Closed -$4.99M – 2234
2021
Q2 		$4.99M Buy
+394,214
New +$4.33M 0.05% 461

Other funds holding EOLS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Schonfeld Strategic Advisors's EOLS Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of Evolus (EOLS) in Q2 2025, closing a stake of 13,085 shares — an estimated $157K sold.

Schonfeld Strategic Advisors first reported a position in EOLS in Q2 2021 and held it in 10 quarters. The position peaked at $4.99M in Q2 2021. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 13,085 Evolus shares in Q2 2025, an estimated $157K.
  • Schonfeld Strategic Advisors first reported a position in Evolus in Q2 2021 and held it in 10 quarters.
  • Schonfeld Strategic Advisors's Evolus position peaked at $4.99M in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.